RecallDepth
Class I Terminated

VITRAKVI (larotractenib) oral solution, 20mg/mL, 100 mL bottle, Rx only, Manufactured for Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ 07981. NDC 50419-392-01

Company
Bayer Healthcare Pharmaceuticals, Inc.
Recall Initiated
November 6, 2023
Posted
December 6, 2023
Recall Number
D-0145-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
192 bottles
Firm Location
Whippany, NJ, United States

Reason for Recall

Microbial Contamination of Non-Sterile Products: microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testing

Distribution

Product was distributed to specialty pharmacies and distributors nationwide who may have further distributed the product.

Lot / Code Info

Lot# 2114228, EXP. 02/29/2024

More recalls by Bayer Healthcare Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class I Drug recalls